617 Effects of SGLT2 inhibitors on left and right ventricular function in a real-world diabetic population Article Swipe

PDF

Alexios Sotirios Kotinas , Mauro Gitto , Riccardo Terzi , Angelo Oliva , Jorgele Zagoreo , Bernhard Reimers , Giulio Stefanini , Marco Mirani , Giuseppe Favacchio , Gianluigi Condorelli , Cristina Panico ·

YOU? · · 2021 · Open Access · · DOI: https://doi.org/10.1093/eurheartj/suab139.018

Aims Heart failure (HF) is a pandemic and despite improvements in therapy, the mortality rate has remained unacceptably high. Sodium glucose cotransporter-2 inhibitors (SGLT2i) have emerged as a promising new class of glucose-lowering drugs, reducing HF-related outcomes across all ejection fraction ranges in clinical trials. However, few studies have assessed their efficacy using echocardiography imaging in a real-world setting. Methods and results Type 2 diabetes mellitus (T2DM) patients treated with SGLT2i from 2015 to 2020 were enrolled in a retrospective observational study. Clinical, biochemical, and echocardiographic data at baseline and 6 and 12 months after treatment initiation were collected. Of the 459 patients screened, 312 (68%) patients completed 1 year of SGLT2i therapy. Side effects were developed in 92 (20%) patients leading them to stop treatment pre-maturely, while 55 (12%) were lost to follow-up. From the 312 patients who completed 1 year of treatment, 83 patients had echocardiography data before initiation and after either 6 or 12 months of treatment and were included in the data analysis. Sample’s average age was 65.78 ± 8.53 years, 23 (27.7%) were females, and the mean BMI was 32.10 ± 6.29 kg/m2. At baseline patients had Hb1Ac 7.94 ± 1.80% and the mean duration of diabetes was 11.19 ± 8.54 years. 59 (71.1%) patients were asymptomatic (NYHA I) at baseline. The mean left ventricular ejection fraction (LVEF) at baseline was 48.40 ± 10.89%, while mean left ventricular end-diastolic volume (LVEDV) was 127.96 ± 41.84 ml. Mean pulmonary artery systolic pressure (PASP) was 33.63 ± 7.89 mmHg and mean tricuspid annular plane systolic excursion (TAPSE) was 20.18 ± 4.17 mm before treatment started. Mean E/e′ ratio at baseline was 9.75 ± 3.50. Mean septal wall thickness before therapy was initiated was 12.05 ± 1.80 mm while mean anterior wall thickness was 11.22 ± 1.52 mm. Almost all of the patients had at least one cardiovascular risk factor, hypertension being the most common (77, 92.8%), while 53 (63.9%) patients had a history of coronary artery disease (CAD), of which 42 (50.6%) had suffered a myocardial infarction. All-cause HF was present in 31 (37.3%) patients (19 HFrEF, 7 HFmrEF, 5 HFpEF). After a mean of 12.94 ± 7.91 months of SGLT2i treatment, left ventricular function was improved as LVEF was increased to 50.62 ± 10.04% (+2.22%, P = 0.018), while LVEDV was reduced to 123.24 ± 41.41 ml (−4.72 ml, P = 0.052). A trend towards improvement of the right ventricular function was also observed as TAPSE increased to 21.45 ± 3.92 mm (+1.27 mm, P = 0.076). PASP remained rather stable (−0.83 mm, P = 0.620), as well as the E/e′ ratio (−0.11, P = 0.857). Septal wall thickness was found unchanged (−0.16 mm, P = 0.449), as well as the anterior wall thickness (−0.63 mm, P = 0.143). After 1 year of treatment the number of asymptomatic patients remained stable (60, P = 0.863). Conclusions SGLT2i improved left ventricular systolic function in a sample of real-world diabetic patients, as shown by the changes in LVEF and LVEDV. A trend towards right ventricular function improvement was also recorded, demonstrated by the TAPSE increase. These findings highlight SGLT2i action on ventricular function and might be hypothesis generating to further elucidate their cardiovascular mechanism of action, beyond their already noted diuretic effect.

Related Topics

Concepts

Medicine Ejection fraction Internal medicine Asymptomatic Diabetes mellitus Heart failure Cardiology Population Endocrinology Environmental health

Metadata

Type: article
Language: en
Landing Page: https://doi.org/10.1093/eurheartj/suab139.018
PDF: https://academic.oup.com/eurheartjsupp/article-pdf/23/Supplement_G/suab139.018/41683677/suab139.018.pdf
OA Status: bronze
Cited By: 3
Related Works: 10
OpenAlex ID: https://openalex.org/W4200488590

All OpenAlex metadata

Raw OpenAlex JSON

OpenAlex ID: https://openalex.org/W4200488590

Canonical identifier for this work in OpenAlex
DOI: https://doi.org/10.1093/eurheartj/suab139.018

Digital Object Identifier
Title: 617 Effects of SGLT2 inhibitors on left and right ventricular function in a real-world diabetic population

Work title
Type: article

OpenAlex work type
Language: en

Primary language
Publication year: 2021

Year of publication
Publication date: 2021-12-01

Full publication date if available
Authors: Alexios Sotirios Kotinas, Mauro Gitto, Riccardo Terzi, Angelo Oliva, Jorgele Zagoreo, Bernhard Reimers, Giulio Stefanini, Marco Mirani, Giuseppe Favacchio, Gianluigi Condorelli, Cristina Panico

List of authors in order
Landing page: https://doi.org/10.1093/eurheartj/suab139.018

Publisher landing page
PDF URL: https://academic.oup.com/eurheartjsupp/article-pdf/23/Supplement_G/suab139.018/41683677/suab139.018.pdf

Direct link to full text PDF
Open access: Yes

Whether a free full text is available
OA status: bronze

Open access status per OpenAlex
OA URL: https://academic.oup.com/eurheartjsupp/article-pdf/23/Supplement_G/suab139.018/41683677/suab139.018.pdf

Direct OA link when available
Concepts: Medicine, Ejection fraction, Internal medicine, Asymptomatic, Diabetes mellitus, Heart failure, Cardiology, Population, Endocrinology, Environmental health

Top concepts (fields/topics) attached by OpenAlex
Cited by: 3

Total citation count in OpenAlex
Citations by year (recent): 2025: 1, 2024: 1, 2023: 1

Per-year citation counts (last 5 years)
Related works (count): 10

Other works algorithmically related by OpenAlex

Full payload

id	https://openalex.org/W4200488590
doi	https://doi.org/10.1093/eurheartj/suab139.018
ids.doi	https://doi.org/10.1093/eurheartj/suab139.018
ids.openalex	https://openalex.org/W4200488590
fwci	0.38426711
type	article
title	617 Effects of SGLT2 inhibitors on left and right ventricular function in a real-world diabetic population
biblio.issue	Supplement_G
biblio.volume	23
biblio.last_page
biblio.first_page
topics[0].id	https://openalex.org/T10401
topics[0].field.id	https://openalex.org/fields/27
topics[0].field.display_name	Medicine
topics[0].score	0.9997000098228455
topics[0].domain.id	https://openalex.org/domains/4
topics[0].domain.display_name	Health Sciences
topics[0].subfield.id	https://openalex.org/subfields/2712
topics[0].subfield.display_name	Endocrinology, Diabetes and Metabolism
topics[0].display_name	Diabetes Treatment and Management
topics[1].id	https://openalex.org/T10821
topics[1].field.id	https://openalex.org/fields/27
topics[1].field.display_name	Medicine
topics[1].score	0.9934999942779541
topics[1].domain.id	https://openalex.org/domains/4
topics[1].domain.display_name	Health Sciences
topics[1].subfield.id	https://openalex.org/subfields/2705
topics[1].subfield.display_name	Cardiology and Cardiovascular Medicine
topics[1].display_name	Cardiovascular Function and Risk Factors
topics[2].id	https://openalex.org/T11339
topics[2].field.id	https://openalex.org/fields/13
topics[2].field.display_name	Biochemistry, Genetics and Molecular Biology
topics[2].score	0.9922999739646912
topics[2].domain.id	https://openalex.org/domains/1
topics[2].domain.display_name	Life Sciences
topics[2].subfield.id	https://openalex.org/subfields/1312
topics[2].subfield.display_name	Molecular Biology
topics[2].display_name	Metabolism, Diabetes, and Cancer
is_xpac	False
apc_list
apc_paid
concepts[0].id	https://openalex.org/C71924100
concepts[0].level	0
concepts[0].score	0.9539047479629517
concepts[0].wikidata	https://www.wikidata.org/wiki/Q11190
concepts[0].display_name	Medicine
concepts[1].id	https://openalex.org/C78085059
concepts[1].level	3
concepts[1].score	0.8403083086013794
concepts[1].wikidata	https://www.wikidata.org/wiki/Q641303
concepts[1].display_name	Ejection fraction
concepts[2].id	https://openalex.org/C126322002
concepts[2].level	1
concepts[2].score	0.7271867990493774
concepts[2].wikidata	https://www.wikidata.org/wiki/Q11180
concepts[2].display_name	Internal medicine
concepts[3].id	https://openalex.org/C2777910003
concepts[3].level	2
concepts[3].score	0.7031817436218262
concepts[3].wikidata	https://www.wikidata.org/wiki/Q1707292
concepts[3].display_name	Asymptomatic
concepts[4].id	https://openalex.org/C555293320
concepts[4].level	2
concepts[4].score	0.6077463626861572
concepts[4].wikidata	https://www.wikidata.org/wiki/Q12206
concepts[4].display_name	Diabetes mellitus
concepts[5].id	https://openalex.org/C2778198053
concepts[5].level	2
concepts[5].score	0.6058434247970581
concepts[5].wikidata	https://www.wikidata.org/wiki/Q181754
concepts[5].display_name	Heart failure
concepts[6].id	https://openalex.org/C164705383
concepts[6].level	1
concepts[6].score	0.5718933939933777
concepts[6].wikidata	https://www.wikidata.org/wiki/Q10379
concepts[6].display_name	Cardiology
concepts[7].id	https://openalex.org/C2908647359
concepts[7].level	2
concepts[7].score	0.5050519108772278
concepts[7].wikidata	https://www.wikidata.org/wiki/Q2625603
concepts[7].display_name	Population
concepts[8].id	https://openalex.org/C134018914
concepts[8].level	1
concepts[8].score	0.10201042890548706
concepts[8].wikidata	https://www.wikidata.org/wiki/Q162606
concepts[8].display_name	Endocrinology
concepts[9].id	https://openalex.org/C99454951
concepts[9].level	1
concepts[9].score	0.0
concepts[9].wikidata	https://www.wikidata.org/wiki/Q932068
concepts[9].display_name	Environmental health
keywords[0].id	https://openalex.org/keywords/medicine
keywords[0].score	0.9539047479629517
keywords[0].display_name	Medicine
keywords[1].id	https://openalex.org/keywords/ejection-fraction
keywords[1].score	0.8403083086013794
keywords[1].display_name	Ejection fraction
keywords[2].id	https://openalex.org/keywords/internal-medicine
keywords[2].score	0.7271867990493774
keywords[2].display_name	Internal medicine
keywords[3].id	https://openalex.org/keywords/asymptomatic
keywords[3].score	0.7031817436218262
keywords[3].display_name	Asymptomatic
keywords[4].id	https://openalex.org/keywords/diabetes-mellitus
keywords[4].score	0.6077463626861572
keywords[4].display_name	Diabetes mellitus
keywords[5].id	https://openalex.org/keywords/heart-failure
keywords[5].score	0.6058434247970581
keywords[5].display_name	Heart failure
keywords[6].id	https://openalex.org/keywords/cardiology
keywords[6].score	0.5718933939933777
keywords[6].display_name	Cardiology
keywords[7].id	https://openalex.org/keywords/population
keywords[7].score	0.5050519108772278
keywords[7].display_name	Population
keywords[8].id	https://openalex.org/keywords/endocrinology
keywords[8].score	0.10201042890548706
keywords[8].display_name	Endocrinology
language	en
locations[0].id	doi:10.1093/eurheartj/suab139.018
locations[0].is_oa	True
locations[0].source.id	https://openalex.org/S81127
locations[0].source.issn	1520-765X, 1554-2815
locations[0].source.type	journal
locations[0].source.is_oa	False
locations[0].source.issn_l	1520-765X
locations[0].source.is_core	True
locations[0].source.is_in_doaj	False
locations[0].source.display_name	European Heart Journal Supplements
locations[0].source.host_organization	https://openalex.org/P4310311648
locations[0].source.host_organization_name	Oxford University Press
locations[0].source.host_organization_lineage	https://openalex.org/P4310311648
locations[0].license
locations[0].pdf_url	https://academic.oup.com/eurheartjsupp/article-pdf/23/Supplement_G/suab139.018/41683677/suab139.018.pdf
locations[0].version	publishedVersion
locations[0].raw_type	journal-article
locations[0].license_id
locations[0].is_accepted	True
locations[0].is_published	True
locations[0].raw_source_name	European Heart Journal Supplements
locations[0].landing_page_url	https://doi.org/10.1093/eurheartj/suab139.018
indexed_in	crossref
authorships[0].author.id	https://openalex.org/A5036500613
authorships[0].author.orcid
authorships[0].author.display_name	Alexios Sotirios Kotinas
authorships[0].countries	IT
authorships[0].affiliations[0].institution_ids	https://openalex.org/I4210163047
authorships[0].affiliations[0].raw_affiliation_string	Humanitas Research Hospital IRCCS, Italy
authorships[0].institutions[0].id	https://openalex.org/I4210163047
authorships[0].institutions[0].ror	https://ror.org/05d538656
authorships[0].institutions[0].type	healthcare
authorships[0].institutions[0].lineage	https://openalex.org/I4210153126, https://openalex.org/I4210163047
authorships[0].institutions[0].country_code	IT
authorships[0].institutions[0].display_name	IRCCS Humanitas Research Hospital
authorships[0].author_position	first
authorships[0].raw_author_name	Alexios S. Kotinas
authorships[0].is_corresponding	False
authorships[0].raw_affiliation_strings	Humanitas Research Hospital IRCCS, Italy
authorships[1].author.id	https://openalex.org/A5042437965
authorships[1].author.orcid	https://orcid.org/0000-0002-4936-3860
authorships[1].author.display_name	Mauro Gitto
authorships[1].countries	IT
authorships[1].affiliations[0].institution_ids	https://openalex.org/I4210163047
authorships[1].affiliations[0].raw_affiliation_string	Humanitas Research Hospital IRCCS, Italy
authorships[1].institutions[0].id	https://openalex.org/I4210163047
authorships[1].institutions[0].ror	https://ror.org/05d538656
authorships[1].institutions[0].type	healthcare
authorships[1].institutions[0].lineage	https://openalex.org/I4210153126, https://openalex.org/I4210163047
authorships[1].institutions[0].country_code	IT
authorships[1].institutions[0].display_name	IRCCS Humanitas Research Hospital
authorships[1].author_position	middle
authorships[1].raw_author_name	Mauro Gitto
authorships[1].is_corresponding	False
authorships[1].raw_affiliation_strings	Humanitas Research Hospital IRCCS, Italy
authorships[2].author.id	https://openalex.org/A5089401350
authorships[2].author.orcid	https://orcid.org/0000-0003-4305-3172
authorships[2].author.display_name	Riccardo Terzi
authorships[2].countries	IT
authorships[2].affiliations[0].institution_ids	https://openalex.org/I4210163047
authorships[2].affiliations[0].raw_affiliation_string	Humanitas Research Hospital IRCCS, Italy
authorships[2].institutions[0].id	https://openalex.org/I4210163047
authorships[2].institutions[0].ror	https://ror.org/05d538656
authorships[2].institutions[0].type	healthcare
authorships[2].institutions[0].lineage	https://openalex.org/I4210153126, https://openalex.org/I4210163047
authorships[2].institutions[0].country_code	IT
authorships[2].institutions[0].display_name	IRCCS Humanitas Research Hospital
authorships[2].author_position	middle
authorships[2].raw_author_name	Riccardo Terzi
authorships[2].is_corresponding	False
authorships[2].raw_affiliation_strings	Humanitas Research Hospital IRCCS, Italy
authorships[3].author.id	https://openalex.org/A5085102151
authorships[3].author.orcid	https://orcid.org/0000-0003-0561-7563
authorships[3].author.display_name	Angelo Oliva
authorships[3].countries	IT
authorships[3].affiliations[0].institution_ids	https://openalex.org/I4210163047
authorships[3].affiliations[0].raw_affiliation_string	Humanitas Research Hospital IRCCS, Italy
authorships[3].institutions[0].id	https://openalex.org/I4210163047
authorships[3].institutions[0].ror	https://ror.org/05d538656
authorships[3].institutions[0].type	healthcare
authorships[3].institutions[0].lineage	https://openalex.org/I4210153126, https://openalex.org/I4210163047
authorships[3].institutions[0].country_code	IT
authorships[3].institutions[0].display_name	IRCCS Humanitas Research Hospital
authorships[3].author_position	middle
authorships[3].raw_author_name	Angelo Oliva
authorships[3].is_corresponding	False
authorships[3].raw_affiliation_strings	Humanitas Research Hospital IRCCS, Italy
authorships[4].author.id	https://openalex.org/A5062022792
authorships[4].author.orcid
authorships[4].author.display_name	Jorgele Zagoreo
authorships[4].countries	IT
authorships[4].affiliations[0].institution_ids	https://openalex.org/I4210163047
authorships[4].affiliations[0].raw_affiliation_string	Humanitas Research Hospital IRCCS, Italy
authorships[4].institutions[0].id	https://openalex.org/I4210163047
authorships[4].institutions[0].ror	https://ror.org/05d538656
authorships[4].institutions[0].type	healthcare
authorships[4].institutions[0].lineage	https://openalex.org/I4210153126, https://openalex.org/I4210163047
authorships[4].institutions[0].country_code	IT
authorships[4].institutions[0].display_name	IRCCS Humanitas Research Hospital
authorships[4].author_position	middle
authorships[4].raw_author_name	Jorgele Zagoreo
authorships[4].is_corresponding	False
authorships[4].raw_affiliation_strings	Humanitas Research Hospital IRCCS, Italy
authorships[5].author.id	https://openalex.org/A5035013058
authorships[5].author.orcid	https://orcid.org/0000-0002-9890-5582
authorships[5].author.display_name	Bernhard Reimers
authorships[5].countries	IT
authorships[5].affiliations[0].institution_ids	https://openalex.org/I4210163047
authorships[5].affiliations[0].raw_affiliation_string	Humanitas Research Hospital IRCCS, Italy
authorships[5].institutions[0].id	https://openalex.org/I4210163047
authorships[5].institutions[0].ror	https://ror.org/05d538656
authorships[5].institutions[0].type	healthcare
authorships[5].institutions[0].lineage	https://openalex.org/I4210153126, https://openalex.org/I4210163047
authorships[5].institutions[0].country_code	IT
authorships[5].institutions[0].display_name	IRCCS Humanitas Research Hospital
authorships[5].author_position	middle
authorships[5].raw_author_name	Bernhard Reimers
authorships[5].is_corresponding	False
authorships[5].raw_affiliation_strings	Humanitas Research Hospital IRCCS, Italy
authorships[6].author.id	https://openalex.org/A5071506939
authorships[6].author.orcid	https://orcid.org/0000-0002-3558-6967
authorships[6].author.display_name	Giulio Stefanini
authorships[6].countries	IT
authorships[6].affiliations[0].institution_ids	https://openalex.org/I4210163047
authorships[6].affiliations[0].raw_affiliation_string	Humanitas Research Hospital IRCCS, Italy
authorships[6].institutions[0].id	https://openalex.org/I4210163047
authorships[6].institutions[0].ror	https://ror.org/05d538656
authorships[6].institutions[0].type	healthcare
authorships[6].institutions[0].lineage	https://openalex.org/I4210153126, https://openalex.org/I4210163047
authorships[6].institutions[0].country_code	IT
authorships[6].institutions[0].display_name	IRCCS Humanitas Research Hospital
authorships[6].author_position	middle
authorships[6].raw_author_name	Giulio G. Stefanini
authorships[6].is_corresponding	False
authorships[6].raw_affiliation_strings	Humanitas Research Hospital IRCCS, Italy
authorships[7].author.id	https://openalex.org/A5046822593
authorships[7].author.orcid	https://orcid.org/0000-0002-4187-5378
authorships[7].author.display_name	Marco Mirani
authorships[7].countries	IT
authorships[7].affiliations[0].institution_ids	https://openalex.org/I4210163047
authorships[7].affiliations[0].raw_affiliation_string	Humanitas Research Hospital IRCCS, Italy
authorships[7].institutions[0].id	https://openalex.org/I4210163047
authorships[7].institutions[0].ror	https://ror.org/05d538656
authorships[7].institutions[0].type	healthcare
authorships[7].institutions[0].lineage	https://openalex.org/I4210153126, https://openalex.org/I4210163047
authorships[7].institutions[0].country_code	IT
authorships[7].institutions[0].display_name	IRCCS Humanitas Research Hospital
authorships[7].author_position	middle
authorships[7].raw_author_name	Marco Mirani
authorships[7].is_corresponding	False
authorships[7].raw_affiliation_strings	Humanitas Research Hospital IRCCS, Italy
authorships[8].author.id	https://openalex.org/A5052870822
authorships[8].author.orcid	https://orcid.org/0000-0002-2815-8892
authorships[8].author.display_name	Giuseppe Favacchio
authorships[8].countries	IT
authorships[8].affiliations[0].institution_ids	https://openalex.org/I4210163047
authorships[8].affiliations[0].raw_affiliation_string	Humanitas Research Hospital IRCCS, Italy
authorships[8].institutions[0].id	https://openalex.org/I4210163047
authorships[8].institutions[0].ror	https://ror.org/05d538656
authorships[8].institutions[0].type	healthcare
authorships[8].institutions[0].lineage	https://openalex.org/I4210153126, https://openalex.org/I4210163047
authorships[8].institutions[0].country_code	IT
authorships[8].institutions[0].display_name	IRCCS Humanitas Research Hospital
authorships[8].author_position	middle
authorships[8].raw_author_name	Giuseppe Favacchio
authorships[8].is_corresponding	False
authorships[8].raw_affiliation_strings	Humanitas Research Hospital IRCCS, Italy
authorships[9].author.id	https://openalex.org/A5010700645
authorships[9].author.orcid	https://orcid.org/0000-0003-0481-6843
authorships[9].author.display_name	Gianluigi Condorelli
authorships[9].countries	IT
authorships[9].affiliations[0].institution_ids	https://openalex.org/I4210163047
authorships[9].affiliations[0].raw_affiliation_string	Humanitas Research Hospital IRCCS, Italy
authorships[9].institutions[0].id	https://openalex.org/I4210163047
authorships[9].institutions[0].ror	https://ror.org/05d538656
authorships[9].institutions[0].type	healthcare
authorships[9].institutions[0].lineage	https://openalex.org/I4210153126, https://openalex.org/I4210163047
authorships[9].institutions[0].country_code	IT
authorships[9].institutions[0].display_name	IRCCS Humanitas Research Hospital
authorships[9].author_position	middle
authorships[9].raw_author_name	Gianluigi Condorelli
authorships[9].is_corresponding	False
authorships[9].raw_affiliation_strings	Humanitas Research Hospital IRCCS, Italy
authorships[10].author.id	https://openalex.org/A5030483396
authorships[10].author.orcid	https://orcid.org/0000-0002-9198-3676
authorships[10].author.display_name	Cristina Panico
authorships[10].countries	IT
authorships[10].affiliations[0].institution_ids	https://openalex.org/I4210163047
authorships[10].affiliations[0].raw_affiliation_string	Humanitas Research Hospital IRCCS, Italy
authorships[10].institutions[0].id	https://openalex.org/I4210163047
authorships[10].institutions[0].ror	https://ror.org/05d538656
authorships[10].institutions[0].type	healthcare
authorships[10].institutions[0].lineage	https://openalex.org/I4210153126, https://openalex.org/I4210163047
authorships[10].institutions[0].country_code	IT
authorships[10].institutions[0].display_name	IRCCS Humanitas Research Hospital
authorships[10].author_position	last
authorships[10].raw_author_name	Cristina Panico
authorships[10].is_corresponding	False
authorships[10].raw_affiliation_strings	Humanitas Research Hospital IRCCS, Italy
has_content.pdf	True
has_content.grobid_xml	True
is_paratext	False
open_access.is_oa	True
open_access.oa_url	https://academic.oup.com/eurheartjsupp/article-pdf/23/Supplement_G/suab139.018/41683677/suab139.018.pdf
open_access.oa_status	bronze
open_access.any_repository_has_fulltext	False
created_date	2025-10-10T00:00:00
display_name	617 Effects of SGLT2 inhibitors on left and right ventricular function in a real-world diabetic population
has_fulltext	False
is_retracted	False
updated_date	2025-11-06T03:46:38.306776
primary_topic.id	https://openalex.org/T10401
primary_topic.field.id	https://openalex.org/fields/27
primary_topic.field.display_name	Medicine
primary_topic.score	0.9997000098228455
primary_topic.domain.id	https://openalex.org/domains/4
primary_topic.domain.display_name	Health Sciences
primary_topic.subfield.id	https://openalex.org/subfields/2712
primary_topic.subfield.display_name	Endocrinology, Diabetes and Metabolism
primary_topic.display_name	Diabetes Treatment and Management
related_works	https://openalex.org/W2891746874, https://openalex.org/W2481234813, https://openalex.org/W1971710084, https://openalex.org/W2072108749, https://openalex.org/W4390348475, https://openalex.org/W2028196543, https://openalex.org/W3164268473, https://openalex.org/W2920829402, https://openalex.org/W2053992978, https://openalex.org/W2887313104
cited_by_count	3
counts_by_year[0].year	2025
counts_by_year[0].cited_by_count	1
counts_by_year[1].year	2024
counts_by_year[1].cited_by_count	1
counts_by_year[2].year	2023
counts_by_year[2].cited_by_count	1
locations_count	1
best_oa_location.id	doi:10.1093/eurheartj/suab139.018
best_oa_location.is_oa	True
best_oa_location.source.id	https://openalex.org/S81127
best_oa_location.source.issn	1520-765X, 1554-2815
best_oa_location.source.type	journal
best_oa_location.source.is_oa	False
best_oa_location.source.issn_l	1520-765X
best_oa_location.source.is_core	True
best_oa_location.source.is_in_doaj	False
best_oa_location.source.display_name	European Heart Journal Supplements
best_oa_location.source.host_organization	https://openalex.org/P4310311648
best_oa_location.source.host_organization_name	Oxford University Press
best_oa_location.source.host_organization_lineage	https://openalex.org/P4310311648
best_oa_location.license
best_oa_location.pdf_url	https://academic.oup.com/eurheartjsupp/article-pdf/23/Supplement_G/suab139.018/41683677/suab139.018.pdf
best_oa_location.version	publishedVersion
best_oa_location.raw_type	journal-article
best_oa_location.license_id
best_oa_location.is_accepted	True
best_oa_location.is_published	True
best_oa_location.raw_source_name	European Heart Journal Supplements
best_oa_location.landing_page_url	https://doi.org/10.1093/eurheartj/suab139.018
primary_location.id	doi:10.1093/eurheartj/suab139.018
primary_location.is_oa	True
primary_location.source.id	https://openalex.org/S81127
primary_location.source.issn	1520-765X, 1554-2815
primary_location.source.type	journal
primary_location.source.is_oa	False
primary_location.source.issn_l	1520-765X
primary_location.source.is_core	True
primary_location.source.is_in_doaj	False
primary_location.source.display_name	European Heart Journal Supplements
primary_location.source.host_organization	https://openalex.org/P4310311648
primary_location.source.host_organization_name	Oxford University Press
primary_location.source.host_organization_lineage	https://openalex.org/P4310311648
primary_location.license
primary_location.pdf_url	https://academic.oup.com/eurheartjsupp/article-pdf/23/Supplement_G/suab139.018/41683677/suab139.018.pdf
primary_location.version	publishedVersion
primary_location.raw_type	journal-article
primary_location.license_id
primary_location.is_accepted	True
primary_location.is_published	True
primary_location.raw_source_name	European Heart Journal Supplements
primary_location.landing_page_url	https://doi.org/10.1093/eurheartj/suab139.018
publication_date	2021-12-01
publication_year	2021
referenced_works_count	0
abstract_inverted_index.1	109, 141, 465
abstract_inverted_index.2	64
abstract_inverted_index.5	353
abstract_inverted_index.6	91, 155
abstract_inverted_index.7	351
abstract_inverted_index.=	381, 395, 420, 429, 439, 450, 462, 478
abstract_inverted_index.A	397, 503
abstract_inverted_index.P	380, 394, 419, 428, 438, 449, 461, 477
abstract_inverted_index.a	6, 28, 57, 79, 325, 338, 356, 488
abstract_inverted_index.12	93, 157
abstract_inverted_index.23	176
abstract_inverted_index.31	346
abstract_inverted_index.42	334
abstract_inverted_index.53	321
abstract_inverted_index.55	129
abstract_inverted_index.59	208
abstract_inverted_index.83	145
abstract_inverted_index.92	119
abstract_inverted_index.At	189
abstract_inverted_index.HF	342
abstract_inverted_index.I)	214
abstract_inverted_index.Of	100
abstract_inverted_index.as	27, 371, 409, 431, 433, 452, 454, 494
abstract_inverted_index.at	88, 215, 224, 272, 307
abstract_inverted_index.be	528
abstract_inverted_index.by	496, 514
abstract_inverted_index.in	11, 43, 56, 78, 118, 164, 345, 487, 499
abstract_inverted_index.is	5
abstract_inverted_index.ml	391
abstract_inverted_index.mm	265, 290, 416
abstract_inverted_index.of	32, 111, 143, 159, 201, 303, 327, 332, 358, 363, 401, 467, 471, 490, 537
abstract_inverted_index.on	523
abstract_inverted_index.or	156
abstract_inverted_index.to	74, 124, 133, 375, 387, 412, 531
abstract_inverted_index.±	173, 186, 195, 205, 228, 239, 250, 263, 276, 288, 298, 360, 377, 389, 414
abstract_inverted_index.(19	349
abstract_inverted_index.312	105, 137
abstract_inverted_index.459	102
abstract_inverted_index.BMI	183
abstract_inverted_index.The	217
abstract_inverted_index.age	170
abstract_inverted_index.all	39, 302
abstract_inverted_index.and	8, 61, 85, 90, 92, 152, 161, 180, 197, 253, 501, 526
abstract_inverted_index.few	47
abstract_inverted_index.had	147, 192, 306, 324, 336
abstract_inverted_index.has	16
abstract_inverted_index.ml,	393
abstract_inverted_index.ml.	241
abstract_inverted_index.mm,	418, 427, 448, 460
abstract_inverted_index.mm.	300
abstract_inverted_index.new	30
abstract_inverted_index.one	309
abstract_inverted_index.the	13, 101, 136, 165, 181, 198, 304, 315, 402, 434, 455, 469, 497, 515
abstract_inverted_index.was	171, 184, 203, 226, 237, 248, 261, 274, 284, 286, 296, 343, 369, 373, 385, 406, 444, 510
abstract_inverted_index.who	139
abstract_inverted_index.(60,	476
abstract_inverted_index.(77,	318
abstract_inverted_index.(HF)	4
abstract_inverted_index.1.52	299
abstract_inverted_index.1.80	289
abstract_inverted_index.2015	73
abstract_inverted_index.2020	75
abstract_inverted_index.3.92	415
abstract_inverted_index.4.17	264
abstract_inverted_index.6.29	187
abstract_inverted_index.7.89	251
abstract_inverted_index.7.91	361
abstract_inverted_index.7.94	194
abstract_inverted_index.8.53	174
abstract_inverted_index.8.54	206
abstract_inverted_index.9.75	275
abstract_inverted_index.Aims	1
abstract_inverted_index.From	135
abstract_inverted_index.LVEF	372, 500
abstract_inverted_index.Mean	242, 269, 278
abstract_inverted_index.PASP	422
abstract_inverted_index.Side	114
abstract_inverted_index.Type	63
abstract_inverted_index.also	407, 511
abstract_inverted_index.data	87, 149, 166
abstract_inverted_index.from	72
abstract_inverted_index.have	25, 49
abstract_inverted_index.left	219, 232, 366, 483
abstract_inverted_index.lost	132
abstract_inverted_index.mean	182, 199, 218, 231, 254, 292, 357
abstract_inverted_index.mmHg	252
abstract_inverted_index.most	316
abstract_inverted_index.rate	15
abstract_inverted_index.risk	311
abstract_inverted_index.stop	125
abstract_inverted_index.them	123
abstract_inverted_index.wall	280, 294, 442, 457
abstract_inverted_index.well	432, 453
abstract_inverted_index.were	76, 98, 116, 131, 162, 178, 211
abstract_inverted_index.with	70
abstract_inverted_index.year	110, 142, 466
abstract_inverted_index.(12%)	130
abstract_inverted_index.(20%)	120
abstract_inverted_index.(68%)	106
abstract_inverted_index.(NYHA	213
abstract_inverted_index.1.80%	196
abstract_inverted_index.11.19	204
abstract_inverted_index.11.22	297
abstract_inverted_index.12.05	287
abstract_inverted_index.12.94	359
abstract_inverted_index.20.18	262
abstract_inverted_index.21.45	413
abstract_inverted_index.3.50.	277
abstract_inverted_index.32.10	185
abstract_inverted_index.33.63	249
abstract_inverted_index.41.41	390
abstract_inverted_index.41.84	240
abstract_inverted_index.48.40	227
abstract_inverted_index.50.62	376
abstract_inverted_index.65.78	172
abstract_inverted_index.After	355, 464
abstract_inverted_index.Hb1Ac	193
abstract_inverted_index.Heart	2
abstract_inverted_index.LVEDV	384
abstract_inverted_index.TAPSE	410, 516
abstract_inverted_index.These	518
abstract_inverted_index.after	95, 153
abstract_inverted_index.being	314
abstract_inverted_index.class	31
abstract_inverted_index.found	445
abstract_inverted_index.high.	19
abstract_inverted_index.least	308
abstract_inverted_index.might	527
abstract_inverted_index.noted	542
abstract_inverted_index.plane	257
abstract_inverted_index.ratio	271, 436
abstract_inverted_index.right	403, 506
abstract_inverted_index.shown	495
abstract_inverted_index.their	51, 534, 540
abstract_inverted_index.trend	398, 504
abstract_inverted_index.using	53
abstract_inverted_index.which	333
abstract_inverted_index.while	128, 230, 291, 320, 383
abstract_inverted_index.(+1.27	417
abstract_inverted_index.(CAD),	331
abstract_inverted_index.(LVEF)	223
abstract_inverted_index.(PASP)	247
abstract_inverted_index.(T2DM)	67
abstract_inverted_index.10.04%	378
abstract_inverted_index.123.24	388
abstract_inverted_index.127.96	238
abstract_inverted_index.Almost	301
abstract_inverted_index.E/e′	270, 435
abstract_inverted_index.HFrEF,	350
abstract_inverted_index.LVEDV.	502
abstract_inverted_index.SGLT2i	71, 112, 364, 481, 521
abstract_inverted_index.Septal	441
abstract_inverted_index.Sodium	20
abstract_inverted_index.across	38
abstract_inverted_index.action	522
abstract_inverted_index.artery	244, 329
abstract_inverted_index.before	150, 266, 282
abstract_inverted_index.beyond	539
abstract_inverted_index.common	317
abstract_inverted_index.drugs,	34
abstract_inverted_index.either	154
abstract_inverted_index.kg/m2.	188
abstract_inverted_index.months	94, 158, 362
abstract_inverted_index.number	470
abstract_inverted_index.ranges	42
abstract_inverted_index.rather	424
abstract_inverted_index.sample	489
abstract_inverted_index.septal	279
abstract_inverted_index.stable	425, 475
abstract_inverted_index.study.	82
abstract_inverted_index.volume	235
abstract_inverted_index.years,	175
abstract_inverted_index.years.	207
abstract_inverted_index.(27.7%)	177
abstract_inverted_index.(37.3%)	347
abstract_inverted_index.(50.6%)	335
abstract_inverted_index.(63.9%)	322
abstract_inverted_index.(71.1%)	209
abstract_inverted_index.(LVEDV)	236
abstract_inverted_index.(TAPSE)	260
abstract_inverted_index.0.018),	382
abstract_inverted_index.0.052).	396
abstract_inverted_index.0.076).	421
abstract_inverted_index.0.143).	463
abstract_inverted_index.0.449),	451
abstract_inverted_index.0.620),	430
abstract_inverted_index.0.857).	440
abstract_inverted_index.0.863).	479
abstract_inverted_index.10.89%,	229
abstract_inverted_index.92.8%),	319
abstract_inverted_index.HFmrEF,	352
abstract_inverted_index.HFpEF).	354
abstract_inverted_index.Methods	60
abstract_inverted_index.action,	538
abstract_inverted_index.already	541
abstract_inverted_index.annular	256
abstract_inverted_index.average	169
abstract_inverted_index.changes	498
abstract_inverted_index.despite	9
abstract_inverted_index.disease	330
abstract_inverted_index.effect.	544
abstract_inverted_index.effects	115
abstract_inverted_index.emerged	26
abstract_inverted_index.factor,	312
abstract_inverted_index.failure	3
abstract_inverted_index.further	532
abstract_inverted_index.glucose	21
abstract_inverted_index.history	326
abstract_inverted_index.imaging	55
abstract_inverted_index.leading	122
abstract_inverted_index.present	344
abstract_inverted_index.reduced	386
abstract_inverted_index.results	62
abstract_inverted_index.studies	48
abstract_inverted_index.therapy	283
abstract_inverted_index.towards	399, 505
abstract_inverted_index.treated	69
abstract_inverted_index.trials.	45
abstract_inverted_index.(+2.22%,	379
abstract_inverted_index.(SGLT2i)	24
abstract_inverted_index.(−0.16	447
abstract_inverted_index.(−0.63	459
abstract_inverted_index.(−0.83	426
abstract_inverted_index.(−4.72	392
abstract_inverted_index.Abstract	0
abstract_inverted_index.However,	46
abstract_inverted_index.anterior	293, 456
abstract_inverted_index.assessed	50
abstract_inverted_index.baseline	89, 190, 225, 273
abstract_inverted_index.clinical	44
abstract_inverted_index.coronary	328
abstract_inverted_index.diabetes	65, 202
abstract_inverted_index.diabetic	492
abstract_inverted_index.diuretic	543
abstract_inverted_index.duration	200
abstract_inverted_index.efficacy	52
abstract_inverted_index.ejection	40, 221
abstract_inverted_index.enrolled	77
abstract_inverted_index.females,	179
abstract_inverted_index.findings	519
abstract_inverted_index.fraction	41, 222
abstract_inverted_index.function	368, 405, 486, 508, 525
abstract_inverted_index.improved	370, 482
abstract_inverted_index.included	163
abstract_inverted_index.mellitus	66
abstract_inverted_index.observed	408
abstract_inverted_index.outcomes	37
abstract_inverted_index.pandemic	7
abstract_inverted_index.patients	68, 103, 107, 121, 138, 146, 191, 210, 305, 323, 348, 473
abstract_inverted_index.pressure	246
abstract_inverted_index.reducing	35
abstract_inverted_index.remained	17, 423, 474
abstract_inverted_index.setting.	59
abstract_inverted_index.started.	268
abstract_inverted_index.suffered	337
abstract_inverted_index.systolic	245, 258, 485
abstract_inverted_index.therapy,	12
abstract_inverted_index.therapy.	113
abstract_inverted_index.(−0.11,	437
abstract_inverted_index.All-cause	341
abstract_inverted_index.Clinical,	83
abstract_inverted_index.analysis.	167
abstract_inverted_index.baseline.	216
abstract_inverted_index.completed	108, 140
abstract_inverted_index.developed	117
abstract_inverted_index.elucidate	533
abstract_inverted_index.excursion	259
abstract_inverted_index.highlight	520
abstract_inverted_index.increase.	517
abstract_inverted_index.increased	374, 411
abstract_inverted_index.initiated	285
abstract_inverted_index.mechanism	536
abstract_inverted_index.mortality	14
abstract_inverted_index.patients,	493
abstract_inverted_index.promising	29
abstract_inverted_index.pulmonary	243
abstract_inverted_index.recorded,	512
abstract_inverted_index.screened,	104
abstract_inverted_index.thickness	281, 295, 443, 458
abstract_inverted_index.treatment	96, 126, 160, 267, 468
abstract_inverted_index.tricuspid	255
abstract_inverted_index.unchanged	446
abstract_inverted_index.HF-related	36
abstract_inverted_index.Sample’s	168
abstract_inverted_index.collected.	99
abstract_inverted_index.follow-up.	134
abstract_inverted_index.generating	530
abstract_inverted_index.hypothesis	529
abstract_inverted_index.inhibitors	23
abstract_inverted_index.initiation	97, 151
abstract_inverted_index.myocardial	339
abstract_inverted_index.real-world	58, 491
abstract_inverted_index.treatment,	144, 365
abstract_inverted_index.Conclusions	480
abstract_inverted_index.improvement	400, 509
abstract_inverted_index.infarction.	340
abstract_inverted_index.ventricular	220, 233, 367, 404, 484, 507, 524
abstract_inverted_index.asymptomatic	212, 472
abstract_inverted_index.biochemical,	84
abstract_inverted_index.demonstrated	513
abstract_inverted_index.hypertension	313
abstract_inverted_index.improvements	10
abstract_inverted_index.unacceptably	18
abstract_inverted_index.end-diastolic	234
abstract_inverted_index.observational	81
abstract_inverted_index.pre-maturely,	127
abstract_inverted_index.retrospective	80
abstract_inverted_index.cardiovascular	310, 535
abstract_inverted_index.cotransporter-2	22
abstract_inverted_index.echocardiography	54, 148
abstract_inverted_index.glucose-lowering	33
abstract_inverted_index.echocardiographic	86
cited_by_percentile_year.max	95
cited_by_percentile_year.min	89
countries_distinct_count	1
institutions_distinct_count	11
sustainable_development_goals[0].id	https://metadata.un.org/sdg/3
sustainable_development_goals[0].score	0.8899999856948853
sustainable_development_goals[0].display_name	Good health and well-being
citation_normalized_percentile.value	0.62156045
citation_normalized_percentile.is_in_top_1_percent	False
citation_normalized_percentile.is_in_top_10_percent	False